136 related articles for article (PubMed ID: 19173791)
21. Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.
Celik T; Turkoglu EB
Curr Eye Res; 2014 Jan; 39(1):42-6. PubMed ID: 24074291
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
Ohmori K; Hayashi K; Kaise T; Ohshima E; Kobayashi S; Yamazaki T; Mukouyama A
Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
[TBL] [Abstract][Full Text] [Related]
23. Comparative efficacy of olopatadine 0.1% ophthalmic solution versus levocabastine 0.05% ophthalmic suspension using the conjunctival allergen challenge model.
Abelson MB; Greiner JV
Curr Med Res Opin; 2004 Dec; 20(12):1953-8. PubMed ID: 15701212
[TBL] [Abstract][Full Text] [Related]
24. Pre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis.
Shimura M; Yasuda K; Miyazawa A; Otani T; Nakazawa T
Am J Ophthalmol; 2011 Apr; 151(4):697-702.e2. PubMed ID: 21257151
[TBL] [Abstract][Full Text] [Related]
25. [Comparative activity of antihistamines on area under dose-response curve from histamine-induced wheal and flare responses in human skin].
Wang RQ; Zhang HY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):634-8. PubMed ID: 15663222
[TBL] [Abstract][Full Text] [Related]
26. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
Pipkorn P; Costantini C; Reynolds C; Wall M; Drake M; Sanico A; Proud D; Togias A
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis.
Meltzer EO; Hampel FC; Ratner PH; Bernstein DI; Larsen LV; Berger WE; Finn AF; Marple BF; Roland PS; Wall GM; Brubaker MJ; Dimas C; Potts SL; Silver LH; Barnes JR
Ann Allergy Asthma Immunol; 2005 Dec; 95(6):600-6. PubMed ID: 16400902
[TBL] [Abstract][Full Text] [Related]
28. Effect of olopatadine hydrochloride, an anti-histamine drug, on rhinitis induced by intranasal instillation of toluene-2,4-diisocyanate in rats.
Tamura T; Komai M
Int Immunopharmacol; 2008 Jun; 8(6):916-21. PubMed ID: 18442798
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
Avunduk AM; Tekelioglu Y; Turk A; Akyol N
Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
[TBL] [Abstract][Full Text] [Related]
30. Olopatadine versus levocetirizine in chronic urticaria: an observer-blind, randomized, controlled trial of effectiveness and safety.
Sil A; Tripathi SK; Chaudhuri A; Das NK; Hazra A; Bagchi C; Islam CN
J Dermatolog Treat; 2013 Dec; 24(6):466-72. PubMed ID: 23163959
[TBL] [Abstract][Full Text] [Related]
31. Double-blind, crossover comparison of olopatadine and cetirizine versus placebo: suppressive effects on skin response to histamine iontophoresis.
Morita E; Matsuo H; Zhang Y
J Dermatol; 2005 Jan; 32(1):58-61. PubMed ID: 15841664
[TBL] [Abstract][Full Text] [Related]
32. Comparison of the sedating effects of levocetirizine and cetirizine: a randomized, double-blind, placebo-controlled trial.
Tzanetos DB; Fahrenholz JM; Scott T; Buchholz K
Ann Allergy Asthma Immunol; 2011 Dec; 107(6):517-22. PubMed ID: 22123381
[TBL] [Abstract][Full Text] [Related]
33. Comparison of preservative-free ketotifen fumarate and preserved olopatadine hydrochloride eye drops in the treatment of moderate to severe seasonal allergic conjunctivitis.
Mortemousque B; Bourcier T; Khairallah M; Messaoud R; Brignole-Baudouin F; Renault D; Rebika H; Brémond-Gignac D;
J Fr Ophtalmol; 2014 Jan; 37(1):1-8. PubMed ID: 24388379
[TBL] [Abstract][Full Text] [Related]
34. Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.
Villareal AL; Farley W; Pflugfelder SC
Eye Contact Lens; 2006 Dec; 32(6):272-6. PubMed ID: 17099387
[TBL] [Abstract][Full Text] [Related]
35. Olopatadine: a drug for allergic conjunctivitis targeting the mast cell.
Leonardi A; Quintieri L
Expert Opin Pharmacother; 2010 Apr; 11(6):969-81. PubMed ID: 20307221
[TBL] [Abstract][Full Text] [Related]
36. Cetirizine inhibits bradykinin-induced cutaneous wheal and flare in atopic and healthy subjects.
Fadel R; Ramboer I; Chatterjee N; Rihoux JP; Derde MP
Allergy; 2000 Sep; 55(9):888-91. PubMed ID: 11003455
[TBL] [Abstract][Full Text] [Related]
37. Effect of topical vapocoolant spray on skin test wheal, flare, and pain responses.
Waibel KH; Katial RK
Ann Allergy Asthma Immunol; 2005 Aug; 95(2):149-53. PubMed ID: 16136764
[TBL] [Abstract][Full Text] [Related]
38. A forced choice comfort study of olopatadine hydrochloride 0.1% versus ketotifen fumarate 0.05%.
Artal MN; Luna JD; Discepola M
Acta Ophthalmol Scand Suppl; 2000; (230):64-5. PubMed ID: 11057355
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.
Berger WE; Ratner PH; Casale TB; Meltzer EO; Wall GM
Allergy Asthma Proc; 2009; 30(6):612-23. PubMed ID: 20031007
[TBL] [Abstract][Full Text] [Related]
40. Double dose of cetirizine hydrochloride is effective for patients with urticaria resistant: a prospective, randomized, non-blinded, comparative clinical study and assessment of quality of life.
Okubo Y; Shigoka Y; Yamazaki M; Tsuboi R
J Dermatolog Treat; 2013 Apr; 24(2):153-60. PubMed ID: 21810005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]